Bodycote (BOY) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
13 Jan, 2026Trading performance and revenue trends
Organic revenue growth for the first ten months was 1.0%, with 0.2% growth in the last four months, excluding surcharges.
Revenue for the first ten months reached £643.4m, with energy input costs and surcharges down by GBP 28 million, a 50% reduction.
Specialist Technologies delivered 7.1% organic revenue growth year to date, driven by S3P, HIP, and Surface Technology, with new capacity added in the U.S.
Classical heat treatment revenues declined by 3.3% in the recent four-month period due to lower industrial activity.
Aerospace and defense grew 6.3% in the second half, energy up 11.9%, automotive up 0.5%, while industrial markets fell 6.3%.
Market and segment insights
Specialist Technologies is positioned for premium margins and further growth, with ongoing expansion in addressable markets and applications.
Aerospace growth was mainly in civil, with temporary supply chain headwinds; engine aftermarket sales remain strong.
Energy growth driven by wins in the Middle East and industrial gas turbines in North America, though oil and gas remains volatile.
Automotive outperformed the market in China, Eastern Europe, and Mexico, but overall sector remains weak.
Medical market softness persists due to destocking, but long-term growth drivers remain intact.
Cost management and capital allocation
Cost base remains agile, with variability tied to top-line performance; no structural cost increases expected unless business volume rises.
Cost management has stabilized performance in challenging markets, especially in industrial and auto segments.
Share buyback program is over 75% complete, with 6.74m shares acquired for GBP 45.8 million of GBP 60 million executed.
Net debt (excluding leases) stood at GBP 65.8 million at period end, stable versus half-year, with interim dividend of GBP 12.6 million paid.
Capital allocation remains balanced across organic investment, M&A, dividends, and potential further buybacks, depending on market conditions.
Latest events from Bodycote
- Aerospace-led H2 growth offsets oil and gas weakness; margins dip, but buybacks and investments continue.BOY
H2 202511 Mar 2026 - Profit and margin gains led by Specialist Technologies and Aerospace & Defence, despite ERP impairment.BOY
H1 20242 Feb 2026 - Margin and cash flow gains in 2024, with specialist tech driving growth and strong outlook.BOY
H2 20241 Dec 2025 - Sequential growth and cost control support H2 profit improvement and strategic progress.BOY
H1 202516 Nov 2025 - New structure targets higher growth, >20% margins, and 46% CO2 cut by 2030, with share buyback.BOY
CMD 202413 Jun 2025